Abstract:Abstract Radiotherapy is one of the most common countermeasures for treating a wide range of tumors. However, the radioresistance of cancer cells is still a major limitation for radiotherapy applications. Efforts are continuously ongoing to explore sensitizing targets and develop radiosensitizers for improving the outcomes of radiotherapy. DNA double-strand breaks are the most lethal lesions induced by ionizing radiation and can trigger a series of cellular DNA damage responses (DDRs), including those helping cells recover from radiation injuries, such as the activation of DNA damage sensing and early transduction pathways, cell cycle arrest, and DNA repair. Obviously, these protective DDRs confer tumor radioresistance. Targeting DDR signaling pathways has become an attractive strategy for overcoming tumor radioresistance, and some important advances and breakthroughs have already been achieved in recent years. On the basis of comprehensively reviewing the DDR signal pathways, we provide an update on the novel and promising druggable targets emerging from DDR pathways that can be exploited for radiosensitization. We further discuss recent advances identified from preclinical studies, current clinical trials, and clinical application of chemical inhibitors targeting key DDR proteins, including DNA-PKcs (DNA-dependent protein kinase, catalytic subunit), ATM/ATR (ataxia–telangiectasia mutated and Rad3-related), the MRN (MRE11-RAD50-NBS1) complex, the PARP (poly[ADP-ribose] polymerase) family, MDC1, Wee1, LIG4 (ligase IV), CDK1, BRCA1 (BRCA1 C terminal), CHK1, and HIF-1 (hypoxia-inducible factor-1). Challenges for ionizing radiation-induced signal transduction and targeted therapy are also discussed based on recent achievements in the biological field of radiotherapy.

Progress in Enhancing Radiosensitivity by Inhibition of DNA Double Strand Break Repair

Targeting DNA repair pathways: a novel approach to reduce cancer therapeutic resistance.

Targeting DNA Double-Strand Break (DSB) Repair to Counteract Tumor Radio-resistance

A Nucleophilicity-Engineered DNA Ligation Blockade Nanoradiosensitizer Induces Irreversible DNA Damage to Overcome Cancer Radioresistance

Research Progress on DNA Double-Strand Break Repair in Deinococcus Radiodurans

DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer

Ability to repair DNA double-strand breaks related to cancer susceptibility and radiosensitivity

Recent advances in DNA damage repair mechanism

RESEARCH PROGRESS ON HOMOLOGOUS RECOMBINATION REPAIR MECHANISM IN Deinococcus Radiodurans

Manipulating Radiation‐Sensitive Z‐DNA Conformation for Enhanced Radiotherapy

Targeting the DNA Damage Response and DNA Repair Pathways to Enhance Radiosensitivity in Colorectal Cancer

Hierarchical Multiplexing Nanodroplets for Imaging-Guided Cancer Radiotherapy Via DNA Damage Enhancement and Concomitant DNA Repair Prevention

Molecular mechanisms of sensitivity and resistance to radiotherapy

DNA Repair Pathways in Cancer Therapy and Resistance.

Dual Targeting of DNA Damage Response Proteins Implicated in Cancer Radioresistance

Progress in the Mechanism Study on DNA Strand Breaks in Vitro Induced by Ionizing Radiation

Targeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung Cancer

Cancer Radiosensitizers.

The role and mechanism of long non‐coding RNAs in homologous recombination repair of radiation‐induced DNA damage

Recent Advances in Cancer Therapy Targeting Proteins Involved in DNA Double-Strand Break Repair

Exploiting DNA repair pathways for tumor sensitization, mitigation of resistance, and normal tissue protection in radiotherapy